Shaun Chilton has been named chief operating officer of Clinigen Group Plc as part of a corporate reorganisation linked to an expansion of the company’s product portfolio. Mr Chilton was previously a divisional COO in charge of clinical trial supply and consultancy. The reorganisation will also see Mark Corbett lead the company’s consultancy business and Lorann Morse become senior vice president in charge of clinical trial supply. Ms Morse is joining Clinigen from Myoderm Inc and will be based in Philadelphia, Pennsylvania, US. David Bryant will head up the speciality pharmaceuticals unit while Anton Jenkins has been appointed business development director.
Clinigen announced the appointment on 9 July 2013.
Copyright 2013 Evernow Publishing Ltd